Is It Too Late to Buy Viking Therapeutics Stock?
Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid ...
bovnews3d
Viking Therapeutics Inc (VKTX) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
On Tuesday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $60.6 which represents a decrease of $-2.37 or -3.76% from the prior close of $62.97. The stock opened at $62.46 and ...
Nasdaq4d
Viking Therapeutics (VKTX) Shares Cross Below 200 DMA
In trading on Tuesday, shares of Viking Therapeutics Inc (Symbol: VKTX) crossed below their 200 day moving average of $61.13, changing hands as low as $58.39 per share. Viking Therapeutics Inc ...
Nasdaq4d
VKTX Quantitative Stock Analysis - Benjamin Graham
Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Value Investor model based on the published ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTX
NEW YORK CITY, NY / ACCESSWIRE / November 16, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") (NASDAQ:VKTX). Such investors ...
bovnews5d
Viking Therapeutics Inc (VKTX) Stock Trading Recap
In recent trading, Viking Therapeutics Inc (VKTX) stock price has shown some volatility, fluctuating -6.04% over the last five trades and 9.66% over the past 30 trades. This represents a notable shift ...
Business Insider3d
Oppenheimer Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
Oppenheimer analyst Jay Olson maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target of $164.00. The company’s shares closed yesterday at $55.06.
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.
Stockhouse3d
VKTX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Viking Therapeutics, Inc. Shareholders Who Lost Money
NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viking Therapeutics, Inc. ("Viking Therapeutics, Inc.") (NASDAQ:VKTX) ...
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Viking Therapeutics(NASDAQ: VKTX) is a clinical-stage pharma company that's been eyeing the weight loss market for some time now. During its third-quarter earnings call a few weeks ago, Viking's ...
Investing4d
Viking Therapeutics Inc (VKTX)
Gainers: EKSO +22%. NDRM +13%. AEMD +9%. ALXN +8%. CRVS +7%.Losers: ATNM -17%. VKTX -11%. APTO -10%. ALDX -10%. RGLS -9%.Now read: Alexion: Suspicions Of Improper ...
Yahoo Finance1d
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
In addition, I'll outline why Viking Therapeutics (NASDAQ: VKTX) is an obvious acquisition candidate. Before I became a ...